Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Israel to allow international force into Gaza, Israeli official says
Saudi Arabia reaffirms right to defend its security against drone attacks
Philippines' Marcos puts anti-graft campaign at centre of address to Congress
French police arrest man after knife attack in Paris
France and Spain race to curb wildfires before new heatwave arrivesĀ
